Gastroenteropancreatic neuroendocrine tumors are a heterogeneous group of carcinomas
that remain difficult to treat with conventional cytotoxic regimens. The 2014 American Society …

Treatment options for neuroendocrine tumors (NETs) and carcinomas (NECs) are
expanding. Early-phase studies have shown preliminary evidence of the antitumor activity of …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare malignancies that
originate in the gastrointestinal system. GEP-NETs are typically indolent, but tumors known …

In recent years, there have been important scientific advances in the biologic
characterization of neuroendocrine neoplasms and in their treatment. This review will …

Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) represents a various
family of rare tumours. Surgery is the first choice in GEP-NENs patients with localized …

Neuroendocrine tumors of the gastroenteropancreatic tract remain a difficult array of
neoplasia to treat. Treatment of advanced and metastatic gastroenteropancreatic …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare and heterogeneous
class of neoplasms. While surgical resection is the mainstay of treatment, non-surgical …

Background Gastroenteropancreatic neuroendocrine tumours (GEP NETs) are relatively
uncommon tumours that occur anywhere within the gastrointestinal tract. The prevalence of …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are relatively rare and complex
neoplasms that present many clinical challenges. Most GEP-NETs are sporadic, but they …

Gastroenteropancreatic neuroendocrine tumors (GEP NETs) are unusual and relatively rare
neoplasms that present many clinical challenges. They characteristically synthesize, store …